Medical Devices; Anesthesiology Devices; Classification of the Real-Time Ultrasound Anatomy Visualization and Labeling Device for Ultrasound Guided Regional Anesthesia
Key claim: The FDA is classifying the real-time ultrasound anatomy visualization and labeling device for ultrasound-guided regional anesthesia as Class II (special controls) to provide reasonable assurance of safety and effectiveness while reducing regulatory burdens.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the real-time ultrasound anatomy visualization and labeling device for ultrasound guided regional anesthesia into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the real-time ultrasound anatomy visualization and labeling device for ultrasound guided regional anesthesia. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Why this matters
Class II classification with special controls establishes a defined regulatory pathway for this anesthesia-support device, allowing future similar products to reach clinicians via 510(k) rather than premarket approval. For providers performing ultrasound-guided regional anesthesia, this signals FDA acceptance of anatomy-labeling assistance tools as an appropriate adjunct, potentially expanding availability of such systems in operating rooms and pain clinics.